Tg Therapeutics, INC. (TGTX) SEC Filings — 2024
17 SEC filings for Tg Therapeutics, INC. (TGTX) in 2024.
Filings
- Tg Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- TG Therapeutics Q3 2024: Assets Near Liabilities — 10-Q · Nov 7, 2024
- TG Therapeutics Files 8-K on Operations and Financials — 8-K · Nov 4, 2024
- Tg Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Oct 7, 2024
- TG Therapeutics Files 2023 Annual Report Amendment — 10-K/A · Aug 9, 2024
- TG Therapeutics Terminates Material Agreement — 8-K · Aug 6, 2024
- TG Therapeutics Files 8-K: Director Changes & Officer Compensation Updates — 8-K · Jun 17, 2024
- TG Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 6, 2024
- TG Therapeutics Files 8-K Report — 8-K · May 1, 2024
- TG Therapeutics, Inc. Files Definitive Proxy Statement — DEF 14A · Apr 29, 2024
- TG Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 29, 2024
- TG Therapeutics Files 8-K for Financial Update — 8-K · Feb 28, 2024
- Tg Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Vanguard Group Maintains Significant Passive Stake in TG Therapeutics — SC 13G/A · Feb 13, 2024
- BlackRock Amends TG Therapeutics Stake, Signals Position Update — SC 13G/A · Jan 26, 2024
- State Street Corp Amends TG Therapeutics Stake, Remains Passive Investor — SC 13G/A · Jan 25, 2024
- TG Therapeutics Files 8-K on Material Definitive Agreement — 8-K · Jan 10, 2024